30 closest matches · ranked by relevance
Breast Cancer · Cognitive Change · Cognitive Impairment
Primary: Client Satisfaction Questionnaire — 29.7; 27.9 score on a scale
Cognitive Dysfunction
Primary: MAAT-G Feasibility Completion Rate — 10 Participants
Breast Cancer Female
Primary: Telehealth Usability Questionnaire (TUQ) — 6.38; 6.31 units on a scale
Cognitive Dysfunction · Breast Cancer Survivors
Primary: National Institutes of Health Toolbox - Cognition Domain- Oral Symbol Digit Test — 7; 3 units on a scale — p=<0.05
Cancer-related Problem/Condition · Cognitive Impairment
Primary: Mean of the Functional Assessment of Cancer Therapy-Cognition (FACT-COG) — 155.8; 152.7 score on a scale
Cancer-related Problem/Condition · Cognitive Impairment
Primary: System Usability Scale (SUS) — 90.6 score on a scale
Breast Cancer
Primary: Change in Cognitive Function — -0.05; 0.01; 0.21; 0.17 z-score
Cancer · Insomnia · Cognitive Impairment
Primary: The Functional Assessment of Cancer Therapy - Cognitive Function (FACT-Cog) Version 3 — 39.39; 38.79; 48.28; 44.71 score on a scale
Hematopoietic Stem Cell Transplantation · Cognitive Impairments · Sleep
Primary: Cognitive Functioning (Neuropsychological Tests) — 0.24; 0.16; 0.43; 0.50 z-score
Acute Lymphoblastic Leukemia · Brain Tumors
Primary: Brain White Matter Volume for Patients Versus Sibling Controls — 27; 30.3 percentage — p=<.0001
Cognitive Decline · Chemo-brain
Primary: Change in Visual Working Memory - Delayed Matching to Sample Test — 16; 13; 16 Participants
Myelodysplastic Syndrome · Effects of Chemotherapy · Mild Cognitive Impairment
Primary: Change From Baseline Capture Task Performance at 1- and 3- Months — .103; -.039; .066; .067 change in proportional response time
Elderly Cancer Patients · Cognitive Impairment
Primary: Validation of the Freund Clock Drawing Test, and Its Predefined Cut-off of ≤ 4, as a Screening Tool to Identify Elderly Cancer Patients in Need of a More In-depth…
Chemo Brain · Chemotherapy-related Cognitive Impairment · Chemo Fog
Primary: Change in the Functional Assessment of Cancer Therapy-Cognitive Function (FACT-Cog) PCI Scale — 7.00; 11.55; 16.80; 16.64 units on a scale — p==0.41
Cancer Metastatic to Brain · Brain Metastases, Adult
Primary: Assess the Need for Adaptations to the CALM Intervention as Measured by the Applicability of the 4 CALM Domains — 3.2; 4.0; 4.0; 3.5 score on a scale
Anxiety Disorder · Breast Cancer · Cognition Disorders
Primary: Retention — 71.0; 80.7 percentage of participants
Adult Solid Neoplasm · Lymphoma
Primary: Direct Communication About Age-related Concerns: Number of Discussions Related to the Geriatric Assessment That Occur in the Clinic Visit Between the Patient, Oncology…
Cancer-related Cognitive Difficulties
Primary: Memory Performance as Assessed by Computerized Cognitive Assessment - Mean Values by Arm — 75.2; 82.7; 83.6; 74.3 % correct — p=0.9168
Mood · Cancer Brain
Primary: Recruitment for CALM — 14; 14; 12 Participants
Acute Lymphoblastic Leukemia
Primary: Feasibility of At Home tDCS Intervention — 25 Participants
Cancer
Primary: Interviews — 20 Interviews
Mild Cognitive Impairment
Primary: Change in Objective Cognitive Performance Composite z Score — .24; .14 Z score
Brain Neoplasm · Recurrent Brain Neoplasm
Primary: Intervention Compliance — 0.39; 0.50 Proportion of Participants
Cancer · Young Adult · Pain
Primary: Intervention Satisfaction: Satisfaction With Therapy and Therapist Scale-Revised (STTS-R) — 26.71; 27.33; 28.86; 27.75 scores on a scale — p=0.519
Brain Injury
Primary: Change From Baseline on a Composite Measure (Z-score) of Attention, Working Memory, and Executive Functions — 0.26; .01 Change to Z (composite) score
Chronic Insomnia
Primary: Sleep Efficiency — 79.70; 85.21 percentage of sleep efficiency
Cognitive Dysfunction · Cognitive Impairment · Cognitive Decline
Primary: Agreement Analysis (Agreement to Reference Standard) - Test Group — 76; 18; 2; 8 Participants
Breast Cancer
Primary: Change in Cognitive Function Scores With Intervention - HVLT and COWA — 49.04; 44.93; 42.28; 43.33 score
Breast Cancer · Neurotoxicity
Primary: The Level of Cognitive Dysfunction as Measured by the High Sensitivity Cognitive Screen (HSCS) Overall Score. — 12.2; 12.6; 3.9; 2.6 units on a scale*months — p=0.84
Fatigue · Self Efficacy · Quality of Life
Primary: Cancer-related Fatigue Severity Using The Brief Fatigue Inventory. — 0.56; 4.19; 4.93 Scores on a scale